2025-11-25FDA approves durvalumab for resectable gastric or gastroesophageal junction adenocarcinomaDrugs Imfinzi (durvalumab) · Anti-PD-L1 antibody, fluorouracil · FluoropyrimidineConditionGastrointestinal
2023-08-02FDA approves trifluridine and tipiracil with bevacizumab for previously treated metastatic colorectal cancerTrial SUNLIGHTDrugs LONSURF (trifluridine and tipiracil) · Fluoropyrimidine, bevacizumab · Anti-VEGFR antibodyConditionGastrointestinal
2019-02-22FDA approves Lonsurf for recurrent, metastatic gastric and gastroesophageal junction adenocarcinomaDrug LONSURF (trifluridine/ tipiracil) · FluoropyrimidineConditionGastrointestinal